LRRK2 variant associated with Alzheimer's disease

Neurobiology of Aging

Volumn 32, Issue 11, 2011, Pages 1990-1993

  Zhao, Yi ^a   Ho, P ^a   Yih, Yuen ^a   Chen, C ^d   Lee, W L ^b,c   Tan, E K ^a,b,c  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Alzheimer's disease; LRRK2; Variants

Indexed keywords

LEUCINE RICH REPEAT KINASE 2;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; ASIAN; CANCER CELL CULTURE; CASE CONTROL STUDY; CELL DEATH; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOPTOSIS; CASE-CONTROL STUDIES; CELLS, CULTURED; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES; TRANSFECTION;

EID: 80052638996     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.11.019     Document Type: Article

References (18)

1. Beecham G.W., Martin E.R., Li Y.J., Slifer M.A., Gilbert J.R., Haines J.L., Pericak-Vance M.A. Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. Am. J. Hum. Genet. 2009, 84(1):35-43.
2. Engidawork E., Gulesserian T., Yoo B.C., Cairns N., Lubec G. Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease. Biochem. Biophys. Res. Commun. 2001, 281(1):84-93.
3. Hernandez D., Paisan-Ruiz C., Crawley A., Malkani R., Werner J., Gwinn-Hardy K., Dickson D., Wavrant Devrieze F., Hardy J., Singleton A. The dardarin G 2019 S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases. Neurosci. Lett. 2005, 389(3):137-139.
4. Ho C.C., Rideout H.J., Ribe E., Troy C.M., Dauer W.T. The Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of neurodegeneration. J. Neurosci. 2009, 29(4):1011-1016.
5. Lee E., Hui S., Ho G., Tan E.K., Chen C.P. LRRK2 G2019S and I2020T mutations are not common in Alzheimer's disease and vascular dementia. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2006, 141B(5):549-550.
6. Lu C.S., Wu-Chou Y.H., van Doeselaar M., Simons E.J., Chang H.C., Breedveld G.J., Di Fonzo A., Chen R.S., Weng Y.H., Lai S.C., Oostra B.A., Bonifati V. The LRRK2 Arg1628Pro variant is a risk factor for Parkinson's disease in the Chinese population. Neurogenetics 2008, 9(4):271-276.
7. Lu Y.W., Tan E.K. Molecular biology changes associated with LRRK2 mutations in Parkinson's disease. J. Neurosci. Res. 2008, 86(9):1895-1901.
8. Paisan-Ruiz C., Jain S., Evans E.W., Gilks W.P., Simón J., van der Brug M., López de Munain A., Aparicio S., Gil A.M., Khan N., Johnson J., Martinez J.R., Nicholl D., Carrera I.M., Pena A.S., de Silva R., Lees A., Martí-Massó J.F., Pérez-Tur J., Wood N.W., Singleton A.B. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004, 44(4):595-600.
9. Pericak-Vance M.A., Bass M.P., Yamaoka L.H., Gaskell P.C., Scott W.K., Terwedow H.A., Menold M.M., Conneally P.M., Small G.W., Vance J.M., Saunders A.M., Roses A.D., Haines J.L. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA 1997, 278(15):1237-1241.
10. Ross O.A., Wu Y.R., Lee M.C., Funayama M., Chen M.L., Soto A.I., Mata I.F., Lee-Chen G.J., Chen C.M., Tang M., Zhao Y., Hattori N., Farrer M.J., Tan E.K., Wu R.M. Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease. Ann. Neurol. 2008, 64(1):88-92.
11. Sancho R.M., Law B.M., Harvey K. Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways. Hum. Mol. Genet. 2009, 15;18(20):3955-3968.
12. Tan E.K., Skipper L.M. Pathogenic mutations in Parkinson disease. Hum. Mutat. 2007, 28(7):641-653.
13. Tan E.K., Tan L.C., Lim H.Q., Li R., Tang M., Yih Y., Pavanni R., Prakash K.M., Fook-Chong S., Zhao Y. LRRK2 R1628P increases risk of Parkinson's disease: replication evidence. Hum. Genet. 2008, 124(3):287-288.
14. Tan E.K., Zhao Y., Skipper L., Tan M.G., Di Fonzo A., Sun L., Fook-Chong S., Tang S., Chua E., Yuen Y., Tan L., Pavanni R., Wong M.C., Kolatkar P., Lu C.S., Bonifati V., Liu J.J. The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence. Hum. Genet. 2007, 120(6):857-863.
15. Tan E.K., Lee J., Chen C.P., Wong M.C., Zhao Y. Case control analysis of LRRK2 Gly2385Arg in Alzheimer's disease. Neurobiol. Aging 2009, 30(3):501-502.
16. Tedde A., Bagnoli S., Cellini E., Nacmias B., Piacentini S., Sorbi S. No association between the LRRK2 G2019S mutation and Alzheimer's disease in Italy. Cell. Mol. Neurobiol. 2007, 27(7):877-881.
17. Toft M., Sando S.B., Melquist S., Ross O.A., White L.R., Aasly J.O., Farrer M.J. LRRK2 mutations are not common in Alzheimer's disease. Mech. Ageing Dev. 2005, 126(11):1201-1205.
18. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., Kachergus J., Hulihan M., Uitti R.J., Calne D.B., Stoessl A.J., Pfeiffer R.F., Patenge N., Carbajal I.C., Vieregge P., Asmus F., Müller-Myhsok B., Dickson D.W., Meitinger T., Strom T.M., Wszolek Z.K., Gasser T. Mutations in LRRK2 cause Autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004, 44:601-607.